Movement Alert|10x Genomics Rises 5.82% in Regular Trading, Trading at $45.76

Market Focus07-22

On July 22, 10x Genomics rose 5.82% in regular trading, trading at $45.76/share, with Turnover of $26.46 million.

Within the Life Sciences Tools & Services sector where 10x Genomics belongs, sector performance was broadly divergent. Among individual stocks, Danaher down 13.79%, Thermo Fisher Scientific down 2.28%, Waters up 1.06%, Repligen down 8.28%, Tempus AI up 1.94%.

10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. Its solutions include single cell gene expression, immune profiling, spatial gene expression, and multiome platforms serving academic, government, biopharmaceutical, and biotechnology institutions. The company is headquartered in Pleasanton, California.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment